Actively Recruiting

Phase Not Applicable
Age: 65Years - 85Years
All Genders
NCT06826963

Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study

Led by Universita di Verona · Updated on 2025-03-14

15

Participants Needed

2

Research Sites

50 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is designed to evaluate the safety, feasibility, and effectiveness of a 12-week eccentric exercise program for older adults with sarcopenia (muscle loss) or sarcopenic obesity and chronic heart failure (HF). The program aims to improve physical performance, muscle strength, and overall health without causing excessive strain on participants. Eccentric exercise has shown potential benefits for improving muscle function, and this study will help determine if it is a safe and effective option for individuals with heart failure and muscle loss. Study Goals: The primary aim of this study is to test the feasibility and effectiveness of an eccentric exercise program for older adults with sarcopenia and CHF. The study will monitor physical performance, adherence to the program, and participants' ability to tolerate the exercise, as well as any impact on heart and muscle health. Study Population: A screening visit will be scheduled to determine if individuals meet the criteria to participate in the study. During this visit, a detailed assessment will be made, and if eligible, participants will sign an informed consent form. This study will assess whether a 12-week eccentric exercise program can help improve muscle strength, cardiovascular health, and overall physical performance in individuals with HF and sarcopenia. The program will involve exercising on an eccentric bike, which is designed to reduce strain on the heart while providing effective muscle strengthening benefits. The study will use several physical performance tests to assess the impact of the exercise program, including: 1. Short Physical Performance Battery (SPPB): Evaluates mobility and strength. 2. 6-Minute Walk Test (6MWT): Measures cardiovascular fitness. 3. Handgrip Strength and Leg Strength Tests: Assess upper and lower body muscle strength. 4. Additionally, body composition will be evaluated using tools such as DXA scans and bioelectrical impedance analysis (BIA) to measure muscle mass, fat, and overall health status. The program's adherence and tolerance will be carefully monitored by measuring session completion, intensity, and participant feedback. Primary Outcomes Feasibility Measures: 1. Recruitment and Completion Rate: The ratio of participants recruited to those who successfully complete the study, including post-intervention assessments. 2. Session Attendance: The number of training sessions attended out of the total planned sessions. 3. Adherence to Training Volume: The number of prescribed exercises completed by participants compared to the total planned. 4. Program Tolerance: Evaluated by comparing the Rate of Perceived Exertion (RPE) during sessions to the target RPE. To be considered feasible, the study must meet these criteria: Recruitment \>50%, Follow-up loss \<20%, Median attendance at training sessions \>80%, Median adherence to prescribed volume \>75%, Tolerance to RPE \>70%. Secondary Outcomes Effectiveness Measures: 1. SARC-F: A tool for identifying individuals at risk of sarcopenia, based on self-reported issues like weakness and difficulty walking. 2. Mini Nutritional Assessment (MNA): Evaluates nutritional status to rule out malnutrition, which could affect training outcomes. 3. Mini Mental State Examination (MMSE): Assesses cognitive function. 4. Minnesota Living with Heart Failure Questionnaire: Evaluates how heart failure affects daily life. 5. International Physical Activity Questionnaire (IPAQ): Measures physical activity levels at baseline. In addition to the physical performance tests mentioned, the study will assess muscle mass and fat distribution using DXA scans and BIA, providing a comprehensive view of body composition. Finally, the feasibility of remotely monitoring patients' physical activity to determine the impact of the intervention on their daily lives, specifically in terms of mobility and autonomy is assessed. To this end, patients will be asked to wear a set of five sensors (two on the ankles, two on the wrists, and one on the waist) for at least four days. The Axivity AX6 sensors, chosen for their light weight and long battery life, will collect data used to monitor time spent moving, sitting, and lying down, as well as to assess the quality of the recorded movements.

CONDITIONS

Official Title

Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study

Who Can Participate

Age: 65Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 65 to 85 years
  • Diagnosed with stable heart failure with preserved (≥50%) or reduced (≤40%) ejection fraction
  • Classified as New York Heart Association (NYHA) class 1, 2, or 3
  • Diagnosed with sarcopenia or sarcopenic obesity based on muscle strength and mass criteria:
    • Impaired muscle strength with Five-repetition chair stand test time >15 seconds (normal weight) or >17 seconds (obesity)
    • Reduced muscle mass according to European Working Group on Sarcopenia (EWGSOP) or sarcopenic obesity criteria from ESPEN and EASO
    • EWGSOP Class I skeletal muscle mass index: males ≤10.75 kg/m², females ≤6.75 kg/m²
    • EWGSOP Class II skeletal muscle mass index: males ≤8.50 kg/m², females ≤5.75 kg/m²
    • ESPEN-EASO obesity waist circumference: males ≥102 cm, females ≥88 cm
    • Sarcopenia Class I skeletal muscle index as % body weight: males 31.3–37%, females 22.1–27.6%
    • Sarcopenia Class II: males <31.5%, females <22.1%
Not Eligible

You will not qualify if you...

  • Severe obstructive heart disease
  • Aortic valve stenosis
  • Severe arrhythmias detected during initial stress testing
  • Intracavitary thrombosis
  • Severe pulmonary hypertension (>70 mmHg)
  • History of venous thromboembolism within previous three months
  • History of heart transplantation
  • Medical conditions significantly limiting functional capacity beyond heart failure impact

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Verona

Verona, Verona, Italy, 37131

Actively Recruiting

2

University of Verona

Verona, Verona, Italy, 37131

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here